Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Acknowledgments
- •Contents
- •About the Editor
- •1.6 Acute Gastrointestinal Bleeding
- •1.7 Transjugular Intrahepatic Portosystemic Shunt
- •1.8 Conclusion
- •References
- •2.1 Introduction
- •2.2 History-Taking
- •2.4 Pre-procedure Imaging
- •2.5 Pre-procedure Investigations
- •2.8 Informed Consent
- •2.10 Part Preparation
- •2.11 Antibiotic Prophylaxis
- •References
- •3.1 Introduction
- •3.2 Ultrasonography
- •3.2.1 Advantages
- •1.1 Introduction
- •1.2 Early Beginnings
- •1.3 Catheter-Directed Thrombolysis
- •1.4 Stents
- •1.5 Coronary Angiography
- •3.2.3 Limitations
- •3.3 Fluoroscopy
- •3.3.1 Indications
- •3.3.2 Interventional Fluoroscopy
- •3.3.2.1 Digital Subtraction Angiography
- •3.4 Computed Tomography
- •3.4.2 Indications
- •3.4.3 Limitations
- •3.5 Magnetic Resonance Imaging
- •3.5.3 Limitations
- •3.6.3 Remove Anti-scatter Grid
- •3.6.4 Pulsed Fluoroscopy
- •3.6.5 Checklist
- •3.9 Conclusion
- •References
- •4.1 Introduction
- •4.2 Pharmaceutical Agents
- •4.2.1 Contrast Agents
- •4.2.2 Iodinated Contrast Media (ICM)
- •Pathogenesis
- •Risk Factors
- •Diagnosis
- •Risk Threshold
- •4.5 Conclusion
- •References
- •4.3 Carbon Dioxide
- •4.3.1 Indication
- •4.3.2 Contraindications
- •4.3.3 Equipment
- •4.3.4 Preparation
- •4.3.5 Technique
- •4.3.6 Complications
- •4.3.7 Advantages
- •4.3.8 Disadvantages
- •4.4.1 Thrombolytics
- •First-Generation Thrombolytic Agents
- •Second-Generation Thrombolytic Agents
- •Third-Generation Thrombolytic Agents
- •4.4.1.2 Contraindications
- •4.4.2 Anticoagulants
- •4.4.2.1 Unfractionated Heparin (UFH)
- •Mechanism
- •Indications
- •4.4.2.2 Low-Molecular-Weight Heparin (LMWH)
- •Mechanism
- •Indications
- •Special Considerations
- •4.4.2.3 Warfarin
- •Mechanism
- •Indications
- •Special Considerations
- •4.4.3 Antiplatelet Drugs
- •4.4.3.1 Aspirin
- •Mechanism
- •Recommendations
- •4.4.3.2 Clopidogrel
- •Mechanism
- •Recommendations
- •4.4.3.3 Glycoprotein IIb/IIIa Inhibitors (GPI)
- •Mechanism
- •Recommendations
- •4.4.4 Vasodilators
- •4.4.4.1 Nitroglycerine
- •Mechanism
- •Indications
- •4.4.4.2 Verapamil
- •Mechanism
- •Indications
- •Contraindications
- •Complications
- •4.4.5 Vasoconstrictors
- •4.4.5.1 Mechanism
- •4.4.5.3 Indication
- •4.4.6 Prothrombotics
- •4.4.6.1 Mechanism
- •4.4.6.3 Indications
- •4.4.6.5 Special Considerations
- •5.1 Introduction
- •5.2 Pre-procedure Tasks
- •5.2.4 Pre-anesthetic Evaluation
- •5.3 Anesthesia Techniques
- •5.3.1 Local Anesthesia
- •5.4 Pediatric IR Procedures
- •5.5 Anesthesia Considerations
- •5.11 Conclusion
- •References
- •6.1 Introduction
- •6.3 Pre-procedural Workup
- •6.3.1 Prothrombin Time (PT-INR)
- •6.3.3 Viscoelastic Tests
- •6.4.1 Procedure-Related Bleeding Risk
- •6.5.1 Chronic Liver Disease
- •6.5.2 Chronic Kidney Disease
- •6.5.3 Thrombocytopenia
- •6.5.4 Disseminated Intravascular Coagulation (DIC)
- •6.5.5 Malignancy
- •6.6 Bridge Therapy
- •6.7 Deep Vein Thrombosis (DVT)
- •6.8 Atrial Fibrillation (AF)
- •6.9 Coronary Stents
- •6.10 Conclusion
- •References
- •7.1 Introduction
- •7.4 Embolic Agent Selection
- •7.5.1 Gelfoam Embolization
- •7.5.2 Coil Embolization
- •7.5.3 Amplatzer Vascular Plug Embolization
- •7.5.4 Glue Embolization
- •7.6 Clinical Applications
- •7.6.1.1 Endovascular Approach
- •Parent Artery Preservation [16, 17]
- •Stent or Balloon-Assisted Coiling [20, 21]
- •Multi-Layered Flow-Diverting Stents [22]
- •7.6.1.2 Parent Artery Occlusion
- •Sandwich Technique [19–22]
- •7.6.1.3 Percutaneous Approach [16, 17, 24, 25]
- •7.6.2 Tumoral Embolization
- •7.6.3 AVM Embolization
- •7.6.5 Special Scenario
- •7.6.5.1 Provocative Angiography
- •7.6.5.2 Lower GI Bleeding
- •7.6.5.3 Hepatic Artery Aneurysm
- •7.6.5.4 Renal Artery Aneurysm (RAA)
- •7.7 Newer Embolizations
- •7.7.1 Genicular Artery Embolization
- •7.8 Conclusion
- •References
- •8.1 Introduction
- •8.2 Puncture Needles
- •8.3 Guidewires
- •8.4 Sheath System
- •8.5 Catheters
- •8.6 Microcatheters
- •8.7 Embolizing Agents
- •8.7.1 Gelatin Foam
- •8.7.2 Autologous Blood Clot
- •8.7.3 Thrombin
- •8.7.4 Coils
- •8.7.5 Vascular Plugs
- •8.7.6 Particulate Agents
- •8.7.7 Liquid Embolic Agents
- •8.8 Detachable Balloons
- •References
- •9.1 Introduction
- •9.2 Balloons
- •9.2.1 Basics
- •9.2.7 Balloon Ratings
- •9.2.11 Balloon Catheter Design
- •9.2.13 Complications
- •9.2.14 Occlusion Balloons
- •9.2.15 Angioplasty–Pearls
- •9.3 Stents
- •9.3.4 Raw Material Form
- •9.3.5 Fabrication
- •9.3.6 Geometry
- •9.3.7 Additions
- •9.3.8 Drug-Eluting Stents
- •9.3.10.1 Arterial Indications
- •9.3.10.2 Venous Indications
- •9.3.10.3 Non-vascular Indications
- •9.3.11 Uncovered vs. Covered (PTFE) SEMS
- •9.3.12 Stent Grafts
- •References
- •10: Vascular Access
- •10.1 Introduction
- •10.2 Indications
- •10.3 Hardware
- •10.3.1 Intravenous Cannula
- •10.3.2 Puncture Needle
- •10.3.3 Arterial Access Sheath
- •10.4 Local Anesthesia
- •10.6 General Considerations Before Procedure
- •10.7 Arterial Access
- •10.7.2 Arterial Access Sites
- •10.7.2.1 Common Femoral Artery
- •10.7.2.2 High Brachial or Axillary Artery
- •10.7.2.3 Radial Artery
- •10.7.2.4 Pedal Access [3]
- •10.7.2.5 Others
- •10.8 Post-procedure Care
- •10.8.1 Manual Compression
- •10.8.2 Vascular Closure Devices (VCD)
- •10.9 Complications [5–8]
- •10.10 Venous Access
- •10.10.1 Common Femoral Vein
- •10.10.2 Internal Jugular Vein
- •10.10.3 Subclavian Vein Access
- •10.10.4 Upper Extremity Vein Access
- •10.11 Conclusion
- •References
- •11: Neurointerventions Including Aneurysm Interventions
- •11.1 Introduction
- •11.2 Neurovascular Interventions
- •11.3.1 Introduction
- •11.3.3 Clinical Presentation
- •11.3.8 Endovascular Techniques
- •11.3.9 General Technical Guidelines
- •11.3.10 Simple Coiling
- •11.3.11 Balloon-Assisted Coiling
- •11.3.12 Stent-Assisted Coiling
- •11.3.13 Flow Diverter/Braided Stents
- •11.3.14 Stent Graft
- •11.3.15 Parent Artery Occlusion
- •11.3.16 Endosaccular Devices
- •11.4.1 Pathophysiology
- •References
- •12.1 Introduction
- •12.4 Thrombectomy Techniques
- •12.5 Aspiration Technique
- •12.5.1 Stentriever Technique
- •12.6 Combination Technique
- •12.7 Balloon Guide Catheters (BGC)
- •12.8 Special Situations
- •12.8.1 Posterior Circulation Stroke
- •12.8.2 Tandem Occlusions
- •12.8.3 Intracranial Atherosclerotic Disease (ICAD)
- •12.8.4 Medium Vessel Occlusions (MeVO)
- •12.9 Complications
- •12.10 Immediate Post-procedure Care
- •References
- •13.1 Introduction
- •13.2 Brain AVMs
- •13.2.1 Introduction
- •13.2.2 Epidemiology
- •Embolic Agents
- •Embolization Techniques
- •Embolization by Copolymers: Technical Aspects
- •13.3 Intracranial Dural Arterio-Venous Fistulas (DAVFs)
- •13.4 VGAM
- •13.5 Spinal Vascular Malformations
- •13.5.1 Introduction
- •13.5.2 Anatomy
- •13.5.4.3 Spinal Epidural AVMs
- •13.5.4.4 Metameric AVMs
- •References
- •14: Other Neurointerventions
- •14.1 Introduction
- •14.2 Direct CCF
- •14.2.2 Treatment
- •14.3 Epistaxis
- •14.4 Neck Vessel Pathologies
- •14.4.2 Etiopathogenesis
- •14.4.3 Clinical Presentation
- •14.4.4 Management
- •References
- •15.1 Introduction
- •15.4.2 Embolization Agents
- •15.5 Conclusion
- •References
- •16: Carotid Artery Interventions
- •16.1 Introduction
- •16.2.1 Imaging
- •16.2.2.1 Symptomatic Carotid Artery Stenosis
- •16.2.2.2 Asymptomatic Carotid Artery Stenosis
- •16.2.3 Best Medical Therapy
- •16.3 Carotid Artery Stenting
- •16.3.1 Preprocedure
- •16.3.2 Hardware
- •16.3.2.1 Procedure
- •16.5 Complications
- •16.5.1 Early Complications
- •16.5.2 Late Complications
- •16.6 Internal Carotid Artery Stenting
- •16.7 Conclusion
- •References
- •18.1 Introduction
- •18.2 Anatomical Considerations
- •18.3 Aortic Dissection
- •18.3.1 Introduction
- •18.3.2.3 Natural History
- •18.3.2.4 Imaging Options
- •18.3.2.6 Conventional Management Plan
- •18.4 Aortic Aneurysms
- •18.4.1 Overview
- •18.4.4 Thoraco-Abdominal Aortic Aneurysm
- •18.4.5 Abdominal Aortic Aneurysm (AAA)
- •18.4.5.3 Endovascular Intervention
- •18.4.6.1 Epidemiology
- •18.4.6.3 Pathophysiology
- •18.4.7 PAU
- •18.4.7.1 Imaging
- •18.4.7.2 Prognosis
- •18.4.7.3 Management
- •18.4.8 PAU
- •18.5.1 Access Site
- •18.5.2 Procedure
- •18.5.3 Post-Procedure Care
- •18.5.4 Follow-Up Imaging
- •18.6.1 Device-Related Complications
- •18.6.2 Systemic Complications
- •18.7 Endoleaks
- •References
- •19: Vascular Thoracic Interventions
- •19.1 Introduction
- •19.2 Bronchial Artery Embolization (BAE)
- •19.2.1.3 Pre-Procedure Evaluation
- •19.2.2 Bronchoscopy
- •19.2.2.1 Technique
- •19.2.2.2 Post-Procedure Care
- •19.2.2.3 Complications
- •19.3 Pulmonary Artery Pseudoaneurysm (PAPA)/Pulmonary AVM (PAVM) Embolization
- •19.3.1 Pre-Procedure Evaluation
- •19.3.1.2 Technique
- •19.3.2 Post-Procedure Care
- •19.3.3 Complications
- •19.4.1 Pre-Procedure Evaluation
- •19.4.2 Technique
- •19.4.3 Complications
- •19.4.4 Post-Procedure Follow-Up
- •19.5 Thoracic Duct Interventions
- •19.5.1 Pre-Procedure Evaluation
- •19.5.2 Lymphangiography Technique
- •19.5.3 Thoracic Duct Embolization Technique
- •19.5.4 Complications
- •19.5.4.2 Central Lymphatic Access Complications
- •References
- •20.1 Introduction
- •20.2 Pulmonary Embolism
- •20.2.3 Pulmonary Angiography
- •20.2.3.1 Technique
- •20.2.3.2 Post-Procedure Care
- •20.2.3.3 Complications
- •20.2.4.1 Intravenous Thrombolysis
- •20.2.4.2 Catheter-Directed Thrombolysis
- •20.2.4.3 Mechanical Thrombectomy
- •Rheolytic Thrombectomy Devices
- •Aspiration Thrombectomy Devices
- •20.3.1 Clinical Manifestations [16, 17]
- •20.3.3 Radiological Findings
- •20.3.4 Endovascular Management
- •20.3.4.1 Pre-Procedure Evaluation
- •20.3.4.2 Technique
- •20.3.4.3 Post-Procedure Care
- •20.3.4.5 Current Evidence
- •20.4 Pulmonary Artery Aneurysm
- •20.4.1 Endovascular Management
- •20.4.1.1 Technique
- •References
- •21: Hepatic Arterial Interventions
- •21.1 Introduction
- •21.2 Hepatic Arterial Anatomy
- •21.2.1 Normal Celiac Anatomy
- •21.2.2 Normal Hepatic Artery Anatomy
- •21.2.3 Variant Anatomies
- •21.3.1.2 Contraindications
- •21.3.1.3 Patient Selection
- •21.3.1.4 Patient Preparation
- •21.3.1.6 Response Evaluation
- •21.3.1.7 TACE Failure
- •21.3.1.8 TACE Discontinuation
- •21.3.1.9 Complications
- •21.3.2 Transarterial Radioembolization (TARE)
- •21.3.2.2 Contraindications [24]
- •21.3.2.3 Agents Used
- •21.3.2.4 First Visit (Planning)
- •21.3.2.5 Second Visit (Microsphere Injection)
- •21.3.2.6 Complications
- •21.3.3 Transarterial Bland Embolization (TAE)
- •21.3.4 Hepatic Artery Infusion Chemotherapy (HAIC)
- •21.4.1 Neuroendocrine Liver Metastasis (NELM)
- •21.4.2 Other Liver Metastases
- •21.4.3 Intrahepatic Cholangiocarcinoma (IHCC)
- •21.4.4 Benign Liver Tumors
- •21.4.4.1 Hemangiomas
- •21.4.4.2 Focal Nodular Hyperplasia
- •21.4.4.3 Hepatocellular Adenoma
- •21.4.4.4 Polycystic Liver Disease
- •21.8 Hepatic Parenchyma Repopulation
- •References
- •22.1 Introduction
- •22.2 Transjugular Liver Biopsy (TJLB)
- •22.2.1 Patient Preparation
- •22.2.2 Procedure
- •22.2.3 Post-Procedural Care
- •22.2.4 Complications
- •22.3 Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- •22.3.3 Pre-Procedural Evaluation [12–14]
- •22.3.4 Technique
- •22.3.5 Post-Procedural Care
- •22.3.6.1 Extrahepatic Portal Vein Puncture [18, 19]
- •22.3.6.2 Hepatic Artery Injury [18–20]
- •22.3.7 Discussion
- •22.4 Balloon-Occluded Retrograde Transvenous Obliteration (BRTO)
- •22.4.1 Indications and Contraindications of BRTO
- •22.4.2 Pre-Procedural Evaluation
- •22.4.3 Requirements
- •22.4.4 Sclerosants
- •22.4.5 Relevant Anatomy
- •22.4.6 Techniques
- •22.4.8 Discussion
- •22.5 Portal Vein Thrombosis (PVT)
- •22.6.2 HV/IVC Stenting
- •22.6.3 Tips/Dips
- •22.6.4 HV/IVC Thrombolysis
- •22.6.5 Discussion
- •22.7 Portal Vein Embolization
- •22.7.5 Pre-Procedural Evaluation
- •22.7.6 Techniques
- •22.7.7 Embolizing Materials
- •22.7.8 Hypertrophy Response
- •22.7.11 Discussion
- •22.8 Transjugular Kidney Biopsy (TJKB)
- •22.8.1 Indications
- •22.8.2 Rationale
- •22.8.3 Pre-Procedural Workup
- •22.8.4 Techniques
- •22.9 IVC Filter
- •22.9.2 Patient Preparation
- •22.9.4 Procedure
- •22.9.5 Complications [98, 102]
- •References
- •23.1 Introduction
- •23.2 Anatomy
- •23.2.1 Arterial Anatomy
- •23.2.2 Venous Anatomy
- •23.3 Arterial Interventions
- •23.3.1 Renovascular Hypertension
- •23.3.2 Atherosclerotic Renal Artery Stenosis
- •23.3.3 Non-atherosclerotic RAS
- •23.3.4 Takayasu Arteritis (TA)
- •23.3.5 Fibromuscular Dysplasia (FMD)
- •23.5.2.1 Preprocedural Evaluation
- •23.5.2.2 Preprocedural Instructions
- •23.5.2.3 Procedure
- •23.5.2.4 Angiography
- •23.5.2.5 Balloon Angioplasty
- •23.5.2.6 Cutting Balloon Angioplasty
- •23.5.2.7 Stenting
- •23.5.2.9 Post-Procedural Care
- •23.5.2.10 Complications
- •23.6.1 Procedure
- •23.7 Renal Artery Aneurysms (RAAs)
- •23.8.1 Etiology
- •23.8.2 Clinical Presentation
- •23.8.3 Endovascular Management
- •23.9.1 Angiomyolipoma
- •23.9.2 Renal Cell Carcinoma (RCC)
- •23.10 Venous Interventions
- •23.10.1 Nutcracker Syndrome (NCS)
- •23.10.1.1 Diagnosis
- •23.10.1.2 Management
- •23.10.1.3 Endovascular Management
- •23.10.1.4 Procedure
- •23.10.1.5 Complications
- •23.10.2 Renal Vein Thrombosis
- •23.10.2.1 Clinical Presentation
- •23.10.2.2 Management
- •23.10.2.4 Procedure
- •References
- •24.1 Introduction
- •24.2 Relevant Anatomy
- •24.3 Mesenteric Ischemia
- •24.3.1 Clinical Features
- •24.3.2 Imaging
- •24.3.3 Treatment
- •24.3.3.2 Intra-Arterial Thrombolysis
- •24.3.3.3 Mechanical Thrombectomy
- •24.4 Gastrointestinal Hemorrhage
- •24.4.1 Clinical Features
- •24.4.2 Endoscopy
- •24.4.3 Imaging
- •24.4.4.2 Complications
- •24.5 Bariatric Embolization
- •24.5.1 Technique
- •References
- •25.1 Introduction
- •25.2 Uterine Artery Embolization (UAE)
- •25.2.1 Indications [1, 2]
- •25.2.2 Contraindications [1, 2]
- •25.2.3 Relevant Vascular Anatomy [2]
- •25.2.4 Preprocedural Evaluation
- •25.2.5 Technique
- •25.2.6 Post-Procedural Care
- •25.2.7 Complications
- •25.2.8 Outcome
- •25.3 Prostatic Artery Embolization (PAE)
- •25.3.1 Rationale Behind PAE
- •25.3.2 Indications [17, 18]
- •25.3.3 Contraindications [18]
- •25.3.4 Preprocedural Evaluation [17]
- •25.3.5 Clinical Assessment
- •25.3.7 Imaging
- •25.3.7.1 Ultrasonography (USG)
- •25.3.7.2 Computed Tomography (CT)
- •25.3.7.3 Magnetic Resonance Imaging (MRI)
- •25.3.9 Relevant Vascular Anatomy
- •25.3.10 Technique
- •25.3.11 Complications
- •25.3.12 Post-Procedural Follow-Up
- •25.3.13 Outcome
- •25.4 Varicocele Embolization
- •25.4.1 Indications [22, 26]
- •25.4.4 Relevant Vascular Anatomy
- •25.4.5 Preprocedural Evaluation [23, 25]
- •25.4.6 Technique
- •25.4.6.2 Venous Access [25, 27, 28]
- •25.4.6.3 Venography [25, 27]
- •25.4.6.4 Embolization [25, 27, 29–31]
- •25.4.7 Post-Procedural Care
- •25.4.8 Complications
- •25.4.9 Outcome
- •25.5 Pelvic Congestion Syndrome
- •25.5.1 Indication [38]
- •25.5.2 Contraindications [38]
- •25.5.3 Preprocedural Evaluation
- •25.5.4 Relevant Vascular Anatomy
- •25.5.5 Technique
- •25.5.6 Post-Procedural Care
- •25.5.7 Complications
- •25.5.8 Outcome
- •25.6 Penile Angiography
- •25.6.1 Penile Vascular Anatomy
- •25.6.2 Technique
- •25.6.3 Complications
- •25.6.4 Outcome
- •References
- •26.2 Peripheral Arterial Disease (PAD)
- •26.2.1 Introduction
- •26.2.5.1 Non-imaging/Functional Modalities
- •26.2.5.2 Imaging Evaluation
- •26.2.6 Management Strategies
- •26.2.6.3 Revascularization Strategies
- •26.3.2 Preprocedural Evaluation
- •26.3.5 Complications
- •26.3.6 Stenting
- •26.3.7 Post-Procedure
- •26.5 Recent Advances
- •26.5.2 Drug-Eluting Technology
- •26.5.3 Bioresorbable Stents
- •26.5.6 Pedal Arch Revascularization
- •26.5.7 Percutaneous Deep Vein Arterialization (DVA)
- •26.6 Acute Limb Ischemia
- •26.7 Popliteal Artery Entrapment Syndrome (PAES)
- •26.8 Genicular Artery Embolization (GAE)
- •References
- •27.1 Introduction
- •27.2 Relevant Anatomy
- •27.3 Varicose Veins
- •27.3.1 Clinical Evaluation
- •27.3.2 Physical Examination
- •27.3.3 Sonological Evaluation
- •27.3.3.1 Duplex Sonographical Evaluation
- •27.3.5.1 Thermal Ablation
- •Endovenous Laser Ablation
- •Radiofrequency Ablation
- •Endovenous Steam Ablation
- •27.3.5.2 Non-thermal Ablative Methods
- •Foam Sclerotherapy
- •Cyanoacrylate Closure (CAC)
- •Mechanochemical Ablation (MOCA)
- •Cryosclerosis
- •27.4 Deep Vein Thrombosis
- •27.4.1 Diagnosis
- •27.4.1.1 Pre-Test Probability
- •27.4.1.2 D-Dimer Assessment
- •27.4.1.3 Radiological Evaluation
- •27.4.5.1 Catheter-Directed Thrombolysis
- •Single-Session (Second-Generation) Pharmacomechanical Catheter-Directed Thrombolysis
- •27.5.1 Pulmonary Embolism (PE)
- •27.5.2 Clinical Features
- •27.5.3 Imaging Evaluation
- •27.5.4 Management
- •27.5.5 Endovascular Techniques
- •References
- •28.1 Introduction
- •28.3.2 Imaging Evaluation
- •28.4 Endovascular Management
- •28.4.1 Nonmature Fistulas
- •28.4.3 Acute Thrombosis
- •28.5 Central Venous Stenosis
- •28.7 Pseudoaneurysm
- •References
- •29.1 Introduction
- •29.2 Low-Flow Vascular Malformations
- •29.2.1.1 Pre-procedural Requirements
- •29.2.1.2 Procedure
- •29.2.1.3 Post-procedure Care
- •Ethanol
- •Detergent Sclerosant
- •Bleomycin
- •Doxycycline
- •OK-432 (Picibanil)
- •29.2.1.5 Complications
- •29.3 High-Flow Vascular Malformations
- •29.3.1.1 Pre-procedure Evaluation
- •29.3.1.2 Technique
- •29.3.1.3 Complications
- •29.4 Fibro-Adipose Vascular Anomaly (FAVA)
- •29.5 Conclusion
- •References
- •30.1 Introduction
- •30.2 Splenic Injuries
- •30.2.2 Technique
- •30.2.3 Patient Preparation
- •30.2.4 Procedure
- •30.2.5 Embolizing Agent
- •30.2.6 Post-procedural Care
- •30.2.7 Complication
- •30.3 Hepatic Injury
- •30.3.1 Background
- •30.3.2 Indication
- •30.3.3 Technique
- •30.3.4 Patient Preparation
- •30.3.6 Embolization Agent
- •30.3.7 Post-procedural Care
- •30.3.8 Complications
- •30.4 Peripheral Vascular Injuries (PVI)
- •30.4.1 Background
- •30.4.2 Indication
- •30.4.3 Patient Preparation
- •30.4.5 Embolization Agent
- •30.4.6 Post-procedural Care
- •30.4.7 Complications
- •30.5 Pelvic Trauma
- •30.5.1 Background
- •30.5.2 Indication
- •30.5.3 Technique
- •30.5.4 Patient Preparation
- •30.5.6 Embolization Agent
- •30.5.7 Complications
- •30.6 Maxillofacial Injury (MFI)
- •30.6.1 Background
- •30.6.2 Indication
- •30.6.3 Technique
- •30.6.4 Patient Preparation
- •30.6.6 Embolization Agent
- •30.6.7 Complications
- •30.7 Conclusion
- •References
- •31.1 Introduction
- •31.2 Inferior Petrosal Sinus Sampling
- •31.2.2 Cushing Syndrome (CS)
- •31.2.4 Pre-Procedure Instructions
- •31.2.5 Minimum Hardware Required
- •31.2.7 Result Interpretation
- •31.3 Adrenal Venous Sampling
- •31.3.1 Adrenal Gland Anatomy
- •31.3.2 Vascular Anatomy
- •31.3.3 Primary Hyperaldosteronism
- •31.3.5 Pre-Procedure Instructions
- •31.3.6 Minimum Hardware Required
- •31.3.8 Result Interpretation
- •31.4 Pancreatic Venous Sampling
- •31.4.1 Pancreatic Venous Anatomy
- •31.4.3 Pancreatic Neuroendocrine Tumors
- •31.4.4 Pre-Procedure Instructions
- •31.4.5 Minimum Hardware Required
- •31.4.7 Result Interpretation
- •31.5 Ovarian Venous Sampling
- •31.5.1 Anatomy
- •31.5.2 Hyperandrogenism
- •31.5.3 Pre-Procedure Instructions
- •31.5.4 Minimum Hardware Required
- •31.5.6 Result Interpretation
- •31.6.1 Anatomy
- •31.6.2 Pre-Procedure Instructions
- •31.6.3 Minimum Hardware Required
- •31.6.4 Procedure
- •31.6.5 Result Interpretation
- •31.7.1 Pre-Procedure Instructions
- •31.7.2 Minimum Hardware Required
- •31.7.3 Procedure
- •31.7.4 Result Interpretation
- •31.8 Conclusion
- •References
- •32.1 Introduction
- •32.2 Priapism
- •32.3 Erectile Dysfunction
- •32.3.2 Epidemiology
- •32.3.3 Aetiology
- •32.3.4 Pathophysiology
- •32.3.6 Imaging
- •32.3.7 Relevant Anatomy
- •32.3.7.2 Venous Anatomy
- •32.3.8 Penile Doppler
- •32.4.1 Indications
- •32.4.2 Contraindications
- •32.4.3 Equipment
- •32.4.4 Technical Aspects
- •32.4.5 Procedure Timing
- •32.4.6 Outcomes
- •32.4.7 Complications
- •32.4.8 Post-Procedural Care
- •32.5.1 Indications
- •32.5.2 Contraindications
- •32.5.3 Equipment
- •32.5.4 Technical Aspects
- •32.5.5 Outcomes
- •32.5.6 Complications
- •32.6.1 Indications
- •32.6.2 Contraindications
- •32.6.3 Equipment
- •32.6.4 Procedural Planning
- •32.6.5 Technical Aspects
- •32.6.6 Outcomes
- •32.6.7 Complications
- •32.7 Conclusion
- •References
- •33: Image-Guided Biopsy
- •33.1 Introduction
- •33.2 Biopsy Devices
- •33.3 Pre-Procedural Evaluation
- •33.4 Ultrasound-Guided Biopsy
- •33.5 CT-Guided Biopsy
- •33.6 MRI-Guided Biopsy
- •33.7.2 Breast
- •33.7.3 Lung
- •33.7.4 Mediastinum
- •33.7.5 Liver
- •33.7.6 Gallbladder
- •33.7.7 Spleen
- •33.7.8 Bowel
- •33.7.9 Retroperitoneum
- •33.7.11 Pelvis
- •33.7.12 Spine
- •33.7.13 Extremities
- •33.8 Conclusion
- •References
- •34: Image-Guided Drainage Procedures
- •34.1 Introduction
- •34.2 Etiology
- •34.4 Contraindications
- •34.5 Imaging Modalities
- •34.6 Pre-Procedure Evaluation
- •34.8 Post-Procedure Care
- •34.9 Complications
- •34.10.1 Postoperative Fluid Collection
- •34.10.2 Ascites
- •34.10.3 Liver Abscess
- •34.10.4 Peripancreatic Fluid Collection
- •34.10.5 Splenic Abscess
- •34.10.6 Appendicitis
- •34.10.8 Renal Abscess
- •34.10.9 Pelvic Abscess
- •34.10.10 Prostatic Abscess
- •34.11 Summary
- •References
- •35: Ablation Techniques
- •35.1 Introduction
- •35.2 Chemical Ablation
- •35.3 Thermal Ablation Techniques
- •35.3.1 Radiofrequency Ablation
- •35.3.2 Microwave Ablation
- •35.3.3 Cryoablation
- •35.3.4 High-Intensity Focused Ultrasound
- •35.3.5 Laser Ablation
- •35.4 Non-thermal Ablation Techniques
- •35.4.1 Irreversible Electroporation
- •35.6.1 Liver
- •35.6.2 Kidney
- •35.6.3 Lung
- •35.6.4 Breast
- •35.6.5 Thyroid
- •35.6.6 Musculoskeletal System
- •35.6.7 Nerve Ablation
- •35.7 Conclusion
- •References
- •36.1 Introduction
- •36.3 CT-Guided Biopsy
- •36.3.2 Complications
- •36.3.3 Technical Approaches
- •36.3.4.3 Paramaxillary Approach
- •36.3.4.4 Submastoid Approach
- •36.3.4.5 Transoral Approach
- •36.3.5.1 Anterolateral Approach
- •36.3.5.2 Posterolateral Approach
- •36.3.5.3 Posterior Approach
- •36.4 Ultrasound-Guided Biopsy/FNAC
- •36.4.2.5 Carotid Space
- •36.7 Conclusion
- •References
- •37: Nonvascular Thoracic Interventions
- •37.1 Introduction
- •37.2 Thoracic Drainage Procedures
- •37.2.1 Pre-Procedure Evaluation
- •37.2.2 Imaging
- •37.3 Thoracocentesis
- •37.3.1 Indications
- •37.3.2 Relative Contraindications
- •37.3.4 Technique
- •37.4.1 Indications
- •37.4.2 Contraindications
- •37.4.3 Drain Size
- •37.4.5 Post-Insertion Care
- •37.5 Intrapleural Fibrinolytic Therapy
- •37.5.1 Catheter Removal
- •37.6 Practice Points
- •37.7 Indwelling Pleural Catheter Insertion
- •37.7.1 Duration
- •37.8.1 Procedure
- •37.8.2 Trocar Drainage
- •37.8.3 Seldinger Technique
- •37.8.4 Post-Procedure Follow-Up
- •37.8.5 Removal
- •37.9 Complications
- •37.9.1 Thoracentesis Related
- •37.9.2 Drainage Chest Tube Related
- •37.9.3 IPC Related
- •37.11.1 Pre-Procedure Evaluation
- •37.11.3 Technique
- •37.11.4 Post-Procedure Care
- •37.11.5 Complications [11, 14, 15]
- •37.12.1 Indications [11, 19]
- •37.12.2 Contraindications [11, 19]
- •37.12.3 Technique
- •37.12.4 Post-Procedure Care
- •37.12.5 Complications
- •References
- •38.1 Introduction
- •38.2 Biliary Anatomy
- •38.3 Biliary Obstruction
- •38.4 Percutaneous Transhepatic Biliary Drainage
- •38.4.2 Indications
- •38.4.3 Contraindications
- •38.4.4 Technique
- •38.4.5 Post-Procedure Care
- •38.4.6 Complications
- •38.5 Biliary Stenting
- •38.5.1 Indications
- •38.5.2 Technique
- •38.7 Intraluminal Procedures Through Percutaneous Biliary Access
- •38.7.1 Endobiliary Biopsy
- •38.7.2 Intraluminal Brachytherapy
- •38.7.3 Gallstone Extraction
- •38.8 Percutaneous Cholecystostomy
- •38.8.1 Indications
- •38.8.2 Technique
- •References
- •39.1 Introduction
- •39.2 Percutaneous Gastrostomy
- •39.2.1 Indications
- •39.2.2 Contraindications
- •39.2.3 Pre-procedural Work-Up
- •39.2.4 Technique
- •39.2.6 Pull-Type PRG
- •39.3 Percutaneous Jejunostomy
- •39.3.1 Indications
- •39.3.2 Technique
- •39.4 Percutaneous Cecostomy
- •39.4.1 Indications
- •39.4.2 Technique
- •39.4.3 Post-procedure Care
- •39.5.1 Technique
- •39.6.1 Technique
- •39.6.3 Malignant Tracheoesophageal Fistula Stenting
- •39.6.5 Complications
- •References
- •40.1 Introduction
- •40.2 Percutaneous Nephrostomy (PCN)
- •40.2.5 Post-procedure Care
- •40.4.3 Ureteroarterial Fistula
- •References
- •41.1 Introduction
- •41.2 Fallopian Tube Recanalization (FTR)
- •41.2.1 Technique
- •41.2.2 Complications
- •41.2.3 Results
- •41.3 Amniocentesis
- •41.3.1 Indications
- •41.3.2 Contraindications [7]
- •41.3.4 Technique
- •41.3.5 Complications
- •41.4 Chorionic Villous Sampling (CVS)
- •41.4.1 Indications
- •41.4.2 Contraindications
- •41.4.4 Technique
- •41.4.5 Complications
- •41.5.1 Indications [15–19]
- •41.5.2 Contraindications [20–23]
- •41.5.3 Technique [15, 23]
- •41.5.4 Complications [15, 23, 24]
- •41.5.5 Outcome [23]
- •41.6.1 Technique
- •41.6.2 Complications
- •41.7.1 Contraindications
- •41.7.2 Technique
- •41.7.3 Complications
- •41.8.1 Technique
- •41.8.2 Complications
- •41.9.1 Technique
- •41.9.2 Complications [28, 44, 45]
- •References
- •42.1 Introduction
- •42.2 Breast Biopsy
- •42.2.2 USG-Guided Biopsy [1, 2]
- •42.2.3 MG-Guided Biopsy [3, 4]
- •42.2.4 MRI-Guided Biopsy [1, 11–13]
- •42.2.5 Vacuum-Assisted Biopsy [1, 4, 14, 15, 16]

33 Image-Guided Biopsy
423
right external jugular vein, or the right femoral vein may be
used. However, these are associated with a higher risk of
complications. Other contraindications for TJLB include
hepatic vein thrombosis, hydatid cyst, and cholangitis [31].
The procedure is performed in the interventional radiology
suite under strict aseptic precautions. Continuous monitoring
of the blood pressure, pulse, and cardiac rhythm is done
throughout the procedure, especially to look for arrhythmias
when the right atrium is crossed. Intravenous infusion of uids should be done and the patient should be strictly fasting
in order to prepare for the requirement of general anesthesia
in the event of a major complication. USG-guided puncture
of the right IJV is done using a high-frequency linear transducer and an 18G needle. The use of USG helps to identify
the suitable site for puncture, avoiding a thrombosed vein,
the carotid vessels, and pneumothorax. The procedure is
monitored using intermittent uoroscopy and ultrasound, to
ensure that the tip of the needle stays away from the liver
capsule and to watch for contrast leakage from the hepatic
vein [32].
33.7.6 Gallbladder
Surgical resection is considered the gold standard for gall
bladder carcinoma and preoperative biopsy is usually not
recommended. However, tissue diagnosis is recommended in
case of unresectable disease to conrm the presence of
malignancy and guide chemotherapy. Percutaneous biopsy
of the gallbladder is most commonly performed under USG
guidance. CT guidance may be needed in cases of abnormal
gallbladder position and interposed stomach or bowel.
The transhepatic or transperitoneal routes may be taken
using an intercostal or subcostal approach. Use of the coaxial
technique helps to avoid multiple punctures of the gallbladder wall.
In case of irregular wall thickening of the gall bladder,
FNAC is performed using 21–24G needle. Exfoliative cytology can be done from bile aspirate, which can be obtained
without puncturing the neoplasm itself. Core biopsy carries
the risk of perforation of gall bladder, bleeding, and bile leak
due to the larger needle size (16–20G) and is therefore usually avoided. However, when a solid mass is seen completely
replacing the gallbladder, it may be biopsied through the
transhepatic route. Pericholecystic uid must be avoided and
ascites must be drained prior to the biopsy.
Care must be taken to avoid puncturing the posterior wall
of the gallbladder as it would increase the risk of bile leak and
peritonitis. The cystic artery must be identied and avoided.
Complications of biopsy from the biliary tract include pain,
bacteremia, bile leak, peritonitis, and hemobilia [33].
33.7.7 Spleen
Spleen, being a highly vascular organ, is rarely sampled.
However, it may have to be biopsied in certain cases when it
is the only abnormal or accessible organ for tissue sampling,
for example, when a solid focal splenic lesion is detected
with no other systemic site amenable for biopsy. This may
occur in Hodgkin or non-Hodgkin lymphoma, primary
malignancy, metastases from various primaries, and systemic infections.
USG or CT guidance can be used depending on size, location, and accessibility of the lesion depending on overlying
ribs, interposed bowel, and kidney. The shortest possible
path traversing through the least amount of splenic parenchyma is preferred. An 18G coaxial biopsy gun is used and
track embolization using gel foam is performed at the end of
the biopsy [34]. Minor complications include pain and
asymptomatic hematoma in the subcapsular or perinephric
location. Major complications include hemorrhage requiring
blood transfusion or intervention, and infection. However,
percutaneous biopsy of the spleen has a high diagnostic yield
and is safe with a complication rate of 1–2%, comparable to
other solid organs including the liver, kidney, and pancreas
[35].
33.7.8 Bowel
Being a hollow and mobile organ, bowel is less suitable for
percutaneous biopsy as compared to solid organs. Endoscopic
biopsy is more commonly performed, for luminal as well as
mural lesions with the help of endoscopic ultrasound.
Percutaneous biopsy is useful for small bowel lesions in
which endoscopic biopsy is not feasible, or negative, and for
submucosal lesions [36]. In cases where there is mass-like
thickening of the bowel wall, involving a relatively less
mobile segment of the bowel like the cecum, ascending
colon, or descending colon, percutaneous biopsy may be
performed. However, there is risk of bowel perforation, fecal
contamination, and peritonitis, especially if there is associated necrosis.
33.7.9 Retroperitoneum
Kidney masses are sampled under ultrasound guidance.
Adrenal masses are more commonly sampled under CT
guidance. Direct posterior approach is most commonly used,
with the patient in prone position. Care must be taken to
avoid interposed lung and pleura. Triangulation technique
and gantry tilt are used when necessary. Patient can also be

424
N. Baijal and S. H. Chandrashekhara
positioned in the lateral oblique position with the side to be
sampled down in order to minimize respiratory excursions of
the diaphragm. Transhepatic route can be used for an anterior or lateral approach to right adrenal masses, especially
with USG guidance. Transrenal and trans-splenic routes
have also been considered safe for left adrenal masses and
may occasionally be used [4]. It is important to rule out a
pheochromocytoma by laboratory investigations including
serum and urine metanephrines prior to sampling an adrenal
mass as biopsy of pheochromocytoma can induce hypertensive crisis.
Retroperitoneal lymph nodes are sampled using CT guidance through posterior paravertebral approach or using USG
guidance through anterior approach. The choice is based on
visibility and accessibility of the lesion and operator preference. Hydrodissection using normal saline and contrast may
be required to safely advance the needle while avoiding
major vascular structures, especially in para-aortic and aortocaval lymph node biopsy, similar to the paravertebral
approach used in the mediastinum.
Biopsy of the pancreas may be required in case of focal
mass lesions or after a pancreatic transplant. While endoscopic ultrasound is considered safer, it may not be useful for
lesions located in the body and tail of pancreas. In such
cases, percutaneous biopsy is helpful. However, percutaneous biopsy is avoided in resectable disease owing to the risk
of needle track seeding. Various approaches may be direct,
retroperitoneal, transorgan, or trans-mesenteric. These
include the posterior—paravertebral, pararenal, transcaval;
anterior—transgastric and transcolonic; lateral—transhepatic and trans-splenic approach. Posterior approach is used
with CT guidance. Transcaval approach is risky due to the
potential hemorrhagic complications; however, it has been
described using 18G needles. Anterior approach carries an
increased risk of complications due to the intervening bowel
and mesenteric vessels. While the transgastric approach is
considered safe owing to the thick gastric wall which is routinely punctured in EUS-guided procedures, the safety of
trans-colonic approach is not established due to the risk of
fecal contamination. Small bowel can also be safely traversed using 21 or 22G ne needle. However, this should be
avoided while sampling cystic lesions [4]. Transhepatic
approach is used to access the head, while trans-splenic
approach can be used for lesions in the tail of the pancreas.
33.7.10 Omentum andMesentery
Being mobile and vascular, the omentum is difcult to sample. Most common indications for an omental biopsy are
suspected peritoneal tuberculosis and omental metastasis
from ovarian or gastrointestinal carcinoma. Mesenteric
biopsy is indicated in case of mesenteric masses and lymphadenopathy. US guidance is preferred for omental and
supercial peritoneal lesions, while CT guidance may be
preferred for deeper lesions with intervening bowel. For
lesions involving the root of mesentery, a posterior approach
is required. It is important to avoid mesenteric vessels and
the intervening bowel. Manual compression using the ultrasound probe helps to displace the bowel, improve lesion visibility, and shorten the needle path. However, color Doppler
should be used to identify vessels before compression as
mesenteric vessels may collapse under pressure from the
transducer. The blunt stylet can also be used to displace
intervening viscera without piercing them. Hydrodissection
is another technique which can be used to displace organs
and create a safe path for the needle.
Automatic biopsy gun is preferred in USG-guided biopsies due to the rapid ring mechanism which minimizes tissue deection as the mesentery and omentum are mobile
structures. However, coaxial system is used during CT-guided
biopsy [37].
33.7.11 Pelvis
For pelvic lesions located anterior or superior to the urinary
bladder, anterior or lateral transabdominal approaches may
be used under USG or CT guidance. However, there is a
risk of injury to the bladder and bowel, needle deection by
bowel peristalsis, and pain due to peritoneal puncture. The
anterolateral approach through the iliopsoas muscle allows
a safe, extraperitoneal route to access external and internal
iliac nodes, adnexal lesions, and masses along the lateral
pelvic wall. For deeper lesions, such as those in the presacral and perirectal locations, a transgluteal approach
through the caudal part of the greater sciatic foramen is
used. However, there is risk of injury to the sciatic nerve,
sacral plexus, and gluteal vessels. A trans-osseous approach
through the sacrum or ilium is used for lesions not accessible by other approaches. Transrectal and transvaginal
approaches are possible, but are uncomfortable for the
patient and cannot be used for lymph nodes along the lateral pelvic wall [1].
Prostate biopsy can be done blindly or under TRUS, MRI,
or TRUS-MRI fusion guidance. The choice of imaging guidance depends on cost, availability, whether a lesion has been
identied on imaging, and whether prior biopsies have
yielded negative results.
Lesions involving the uterus, cervix, vagina, and vault are
preferably biopsied by the transvaginal route. If the lesion is
not visible externally, especially in cases of suspected vault
recurrence after hysterectomy for carcinoma, TVS-guided
biopsy may be done.

33 Image-Guided Biopsy
425
Unless there is known metastasis, adnexal masses are
usually not sampled as the staging of ovarian cancers is surgical and surgery may be curative. However, if there is
known metastases or the patient is at poor surgical risk, percutaneous biopsy is done.
33.7.12 Spine
Vertebral biopsy is performed using a bone biopsy needle
under CT or uoroscopic guidance. Pre-procedure CT or MRI
is often required to identify the level and extent of involvement.
Indications of vertebral biopsy include bony lesions, spondylodiscitis, lymphoma, plasmacytoma, and metastases. Care must
be taken to avoid the spinal canal and neural foramina.
33.7.13 Extremities
Soft tissue lesions are biopsied under ultrasound guidance. A
contrast-enhanced MRI is often useful in limiting the differential diagnosis and avoiding the neurovascular bundle.
Bone biopsy is performed under CT guidance. MR guidance may be needed for marrow lesions which are not visible
on CT.
In case of suspected malignant bone tumor, the site of the
biopsy tract should be discussed with the orthopedic surgeon
prior to the procedure so that it may be resected if the patient
is eligible for surgical cure. While planning the access, it is
important to consider the surrounding anatomy including the
neurovascular bundle, joint capsule, and cortical thickness of
the bone.
33.8 Conclusion
A thorough knowledge of anatomy is essential to choose the
most appropriate approach for tissue sampling. The shortest
possible path with minimum intervening tissue avoiding
vital structures, is preferred. Review of prior imaging is necessary to select the target lesion with the safest access and
highest likelihood of yielding viable tissue. Various types of
biopsy devices are available and the choice depends on size
and location of the lesion, surrounding structures, cost and
operator preference. Choice of the guiding modality depends
on lesion conspicuity, surrounding anatomy and availability.
Ultrasound is most commonly used, owing to its real-time
capabilities and wide availability. CEUS can be used to
improve visualization of the lesion. CT-guidance is used for
sampling bone, lung, mediastinal and retroperitoneal lesions.
CT uoroscopy adds real-time capabilities at the cost of
increased radiation exposure to the patient and operator.
MRI is reserved for situations when the lesion is not visible
on other modalities, as it is expensive, time-consuming and
requires special equipment which is not widely available.
Imaging guidance increases the safety and diagnostic yield
of biopsy.
References
1. Gupta S, Madoff DC. Image-guided percutaneous needle
biopsy in cancer diagnosis and staging. Tech Vasc Interv Radiol.
2007;10(2):88–101.
2. Charboneau JW, Reading CC, Welch TJ.CT and sonographically
guided needle biopsy: current techniques and new innovations. AJR
Am J Roentgenol. 1990;154(1):1–10.
3. Hopper KD, Abendroth CS, Sturtz KW, Matthews YL, Stevens
LA, Shirk SJ. Automated biopsy devices: a blinded evaluation.
Radiology. 1993;187(3):653–60.
4. Carberry GA, Lubner MG, Wells SA, Hinshaw JL. Percutaneous
biopsy in the abdomen and pelvis: a step-by-step approach. Abdom
Radiol. 2016;41(4):720–42.
5. Broderick LS, Kopecky KK, Cramer H.Image-guided coaxial ne
needle aspiration biopsy with a side-exiting guide. J Comput Assist
Tomogr. 2002;26(2):292–7.
6. Gupta S, Ahrar K, Morello FA, Wallace MJ, Madoff DC, Hicks
ME. Using a coaxial technique with a curved inner needle for
CT-guided ne-needle aspiration biopsy. AJR Am J Roentgenol.
2002;179(1):109–12.
7. Ho LM, Thomas J, Fine SA, Paulson EK.Usefulness of sonographic
guidance during percutaneous biopsy of mesenteric masses. Am J
Roentgenol. 2003;180(6):1563–6.
8. Wu W, Jing X, Qin XG, Lin ZX, Wang J, Qing DR, et al. A
multicenter randomized controlled study of contrast-enhanced
US versus US-guided biopsy of focal liver lesions. Radiology.
2022;305(3):721–8.
9. Huang PY, Tsai MY, Huang JS, Lin PY, Chou CP. Contrastenhanced ultrasound-guided biopsy of suspicious breast lesions on
contrast-enhanced mammography and contrast-enhanced MRI: a
case series. J Med Ultrason. 2023;50(4):521–9.
10. Daniels SP, Mankowski Gettle L, Blankenbaker DG, Lee KS,
Ross AB. Contrast-enhanced ultrasound-guided musculoskeletal biopsies: our experience and technique. Skeletal Radiol.
2021;50(4):673–81.
11. Hussain S.Gantry angulation in CT-guided percutaneous adrenal
biopsy. Am J Roentgenol. 1996;166(3):537–9.
12. vanSonnenberg E, Wittenberg J, Ferrucci JT, Mueller PR, Simeone
JF. Triangulation method for percutaneous needle guidance: the
angled approach to upper abdominal masses. AJR Am J Roentgenol.
1981;137(4):757–61.
13. de Mey J, Op de Beeck B, Meysman M, Noppen M, De Maeseneer
M, Vanhoey M, et al. Real time CT-uoroscopy: diagnostic and
therapeutic applications. Eur J Radiol. 2000;34(1):32–40.
14. Yamamoto S, Matsumoto T, Suda S, Tomita K, Kamei S, Hashida
K, et al. First experience of efcacy and radiation exposure in
320-detector row CT uoroscopy-guided interventions. Br J Radiol.
2021;94(1120):20200754.
15. Sarmento S, Pereira JS, Sousa MJ, Cunha LT, Dias AG, Pereira MF,
etal. The use of needle holders in CTF guided biopsies as a dose
reduction tool. J Appl Clin Med Phys. 2018;19(1):250–8.
16. Genant JW, Vandevenne JE, Bergman AG, Beaulieu CF, Kee ST,
Norbash AM, et al. Interventional musculoskeletal procedures
performed by using MR imaging guidance with a vertically open

426
N. Baijal and S. H. Chandrashekhara
MR unit: assessment of techniques and applicability. Radiology.
2002;223(1):127–36.
17. Hirvonen M, Sinikumpu JJ, Tervonen O, Sequeiros RB.Magnetic
resonance imaging-guided biopsies in children. Acta Radiol Open.
2021;10(11):20584601211053846.
18. Lu DS, Lee H, Farahani K, Sinha S, Lufkin R.Biopsy of hepatic
dome lesions: semi-real-time coronal MR guidance technique. AJR
Am J Roentgenol. 1997;168(3):737–9.
19. Lee MH, Lubner MG, Hinshaw JL, Pickhardt PJ.Ultrasound guidance versus CT guidance for peripheral lung biopsy: performance
according to lesion size and pleural contact. Am J Roentgenol.
2018;210(3):W110–7.
20. Heerink WJ, de Bock GH, de Jonge GJ, Groen HJM, Vliegenthart
R, Oudkerk M.Complication rates of CT-guided transthoracic lung
biopsy: meta-analysis. Eur Radiol. 2017;27(1):138–48.
21. Yeow KM, See LC, Lui KW, Lin MC, Tsao TC, Ng KF, etal. Risk
factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions. J Vasc Interv
Radiol. 2001;12(11):1305–12.
22. Huo YR, Chan MV, Habib AR, Lui I, Ridley L.Pneumothorax rates
in CT-Guided lung biopsies: a comprehensive systematic review and
meta-analysis of risk factors. Br J Radiol. 2020;93(1108):20190866.
23. Drumm O, Joyce EA, de Blacam C, Gleeson T, Kavanagh J,
McCarthy E, et al. CT-guided lung biopsy: effect of biopsyside down position on pneumothorax and chest tube placement.
Radiology. 2019;292(1):190–6.
24. Naja A, Al Ahmar M, Bonnet B, Delpla A, Kobe A, Madani K,
etal. The PEARL approach for CT-guided lung biopsy: assessment
of complication rate. Radiology. 2022;302(2):473–80.
25. Gupta S, Wallace MJ, Morello FA, Ahrar K, Hicks ME.CT-guided
percutaneous needle biopsy of intrathoracic lesions by using the
transsternal approach: experience in 37 patients. Radiology.
2002;222(1):57–62.
26. Gupta S, Seaberg K, Wallace MJ, Madoff DC, Morello FA, Ahrar K,
etal. Imaging-guided percutaneous biopsy of mediastinal lesions:
different approaches and anatomic considerations. Radiographics.
2005;25(3):763–86.
27. Bar-Ziv J, Solomon A.The use of a modied direct coronal computed tomographic technique for assessing thoraco-abdominal
problems. Gastrointest Radiol. 1989;14(3):205–8.
28. Sparchez Z, Mocan T, Hagiu C, Kacso G, Zaharie T, Rusu I,
et al. Real-Time Contrast-Enhanced–Guided Biopsy Compared
with Conventional Ultrasound–Guided Biopsy in the Diagnosis
of Hepatic Tumors on a Background of Advanced Chronic Liver
Disease: A Prospective, Randomized, Clinical Trial. Ultrasound
Med Biol. 2019;45(11):2915–24.
29. Stattaus J, Kuehl H, Ladd S, Schroeder T, Antoch G, Baba HA,
etal. CT-guided biopsy of small liver lesions: visibility, artifacts,
and corresponding diagnostic accuracy. Cardiovasc Intervent
Radiol. 2007;30(5):928–35.
30. Schmidt VF, Öcal O, Walther V, Fabritius MP, Dietrich O,
Kazmierczak PM, etal. Clinical benets of MRI-guided freehand
biopsy of small focal liver lesions in comparison to CT guidance.
Eur Radiol [Internet]. 2024 Feb 6 [cited 2024 Feb 16]. Available
from: https://doi.org/10.1007/s00330- 024- 10623- 9.
31. Nousbaum JB, Cadranel JF, Bonnemaison G, Bourlière M, Chiche
L, Chor H, et al. Clinical practice guidelines on the use of liver
biopsy. Gastroenterol Clin Biol. 2002;26(10):848–78.
32. Dohan A, Guerrache Y, Boudiaf M, Gavini JP, Kaci R, Soyer
P. Transjugular liver biopsy: indications, technique and results.
Diagn Interv Imaging. 2014;95(1):11–5.
33. Posa A, Steri L, Longo V, Mazza G, Barbieri P, Iezzi
R.Percutaneous gallbladder biopsy: indications, technique and
complications. Livers. 2022;2(3):178–84.
34. McInnes MDF, Kielar AZ, Macdonald DB. Percutaneous imageguided biopsy of the spleen: systematic review and meta-analysis
of the complication rate and diagnostic accuracy. Radiology.
2011;260(3):699–708.
35. Olson MC, Atwell TD, Harmsen WS, Konrad A, King RL, Lin
Y, et al. Safety and accuracy of percutaneous image-guided core
biopsy of the spleen. Am J Roentgenol. 2016;206(3):655–9.
36. Perez-Johnston R, Hahn PF, Shenoy-Bhangle AS, Shelly MJ,
Gervais DA, Arellano RS.Percutaneous biopsy of focal lesions of
the gastrointestinal tract. Abdom Imaging. 2013;38(6):1197–202.
37. Cornman-Homonoff J, Madoff DC. Image-guided biopsy of
mesenteric, omental, and peritoneal disease. Dig Dis Interv.
2018;02(2):106–15.

Image-Guided Drainage Procedures
VishnuPrasadPulappadi andS.H.Chandrashekhara
34
Key Messages
1. Fluid collections can develop in any part of the body due
to a variety of causes.
2. Imaging plays an important role not only in diagnosing
the uid collection but also in guiding the drainage.
3. Large infected uid collections require drainage along
with appropriate antibiotics for elimination of the
infection.
4. USG is the most commonly used modality for guiding
drainage because of its widespread availability and ease
of use.
5. CT is used as guidance in deep-seated and air-containing
collections which are poorly visualized on USG.
6. While single-time aspiration is sufcient for small uid
collections, catheter drainage is required for larger ones.
34.1 Introduction
Drainage of abscesses and other uid collections is one of
the most commonly performed image-guided procedures.
Drainage is essential for the control of infection as the parenterally administered antibiotics are ineffective against the
infective agents contained within the abscess. It is most commonly performed under ultrasound or CT guidance. Being a
less invasive procedure, image-guided drainage is preferred
over surgical drainage for abscesses that are located within
the abdominal or thoracic cavities. It is associated with less
morbidity than surgical drainage.
V. P. Pulappadi (*)
Kovai Medical Center and Hospital, Coimbatore, India
S. H. Chandrashekhara
Department of Radiodiagnosis and Interventional Radiology,
IRCH, All India Institute of Medical Sciences, Delhi, India
34.2 Etiology
Fluid collections may occur in any organ or any potential
space in the body. Etiology can be broadly classied into [1]:
• Benign parenchymal or mesothelial cystic lesions.
• Infections—bacterial, fungal, or parasitic.
• Postoperative—seroma or lymphocele.
• Inammation such as pancreatitis and appendicitis.
• Perforation in the gastrointestinal tract or leakage from
the genitourinary tract.
• Accumulation of extravasated blood—post-traumatic,
rupture of benign or malignant lesions, spontaneous
hemorrhage.
34.3 Indications forDrainage
Fluid collections that are asymptomatic and are not infected
can be left alone to resolve on their own. The indications for
drainage of a uid collection include [1]:
• Diagnostic.
– Diagnostic uid aspiration is done if the etiology of the
uid collection is in doubt.
– Aspiration may be needed to conrm the presence of
infection and for identifying the infectious agent to
decide upon the antibiotic to be used.
• Therapeutic.
– All uid collections that are suspected or conrmed to
have infection need to be drained unless it is too small
in size for percutaneous or surgical drainage. Abscesses
>6cm in size are associated with a high likelihood of
treatment failure when managed with antibiotics alone
and thus require percutaneous drainage [2]. Features
of infection inside a uid collection include fever, leukocytosis, and the presence of air inside the
collection.
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024
S. H. Chandrashekhara (ed.), Textbook of Interventional Radiology, https://doi.org/10.1007/978-981-97-9601-4_34
427

428
V. P. Pulappadi and S. H. Chandrashekhara
– Drainage of a non-infected uid collection is done
when it produces symptoms due to its large size or due
to extrinsic compression on the adjoining organs.
Single-time aspiration is sufcient in uid collections that
are small. Catheter drainage is indicated for large uid collections and collections that contain thick pus.
34.4 Contraindications
There are no absolute contraindications for the drainage of
uid collections. The relative contraindications include [1]:
• Severe uncorrectable coagulopathy.
• Presence of major blood vessels or vital organs along the
expected tract of the needle or the catheter that increases
the risk of bleeding or infectious complications.
• Active hemorrhage within the uid collection, which
requires surgical management or embolization followed
by percutaneous drainage.
• Lack of maturation of abscess, which requires repeat
imaging after a few days for liquefaction.
• Severe hemodynamic instability.
• Severely compromised cardiopulmonary function.
The curvilinear transducer is used for guiding drainage
of intrathoracic or intraabdominal collections, while a linear transducer is used for supercial collections.
Transvaginal USG is used for guiding drainage of uid collections in the adnexa or the rectovaginal pouch. Needle
aspiration of prostatic abscesses is done with the guidance
of transrectal USG.
CT is the preferred modality for abscess drainage if there
is air within the cavity. Intravenous and oral contrast administration can be used to differentiate uid collections from
bowel loops. Delayed phase acquisition helps in visualizing
the ureters and avoiding injury to them while draining retroperitoneal uid collections. Peripancreatic collections are
preferentially drained via the retroperitoneal approach and
CT guidance is often necessary (Fig.34.1). It is also the preferred modality for catheter drainage of pneumothorax and
hydropneumothorax.
Fluoroscopy can be used as an adjunct to USG and CT
during the initial placement of the catheter or during the
repositioning of a displaced catheter. An iodinated contrast
agent injected under uoroscopy helps in identifying the
position of the catheter tip. In addition, it can be used to identify any stulous communication of the uid collection with
the gastrointestinal, genitourinary, or biliary tracts.
34.5 Imaging Modalities
Ultrasonography (USG) is the imaging modality that is most
commonly used for guidance during drainage. It has the
advantages of widespread availability, avoidance of radiation
exposure, real-time guidance, and less procedure time as
compared to the other modalities. USG is used for drainage
of pleural and peritoneal uid and abscesses located within
solid organs such as the liver, kidney, or spleen. However,
uid collections that are deeply located, contain air within,
or have bowel loops overlying them are difcult to target on
USG.
Fig. 34.1 Drainage of
collections under CT
guidance. (a) A uid
collection in left
retroperitoneal and paracolic
gutter drained using an 8F
pigtail catheter. (b) A pelvic
collection drained by the
transgluteal approach
34.6 Pre-Procedure Evaluation
As per the Society of Interventional Radiology (SIR) consensus guidelines, intrathoracic or intraabdominal abscess
drainage is associated with a high risk of periprocedural
bleeding and hence requires routine testing for dysfunctional
coagulation prior to the procedure. The recommended
screening tests are platelet count, hemoglobin level, and prothrombin time/international normalized ratio (PT/INR), and
the recommended thresholds for performing the procedure
are platelet count >50,000/mm3 and PT/INR <1.5. Drainage
of supercially located abscesses and uid collections, such
as joint effusions, are associated with a low risk of bleeding
ab

34 Image-Guided Drainage Procedures
429
complications, as the bleeding can be easily controlled by
manual compression [3].
The most recent imaging studies must be reviewed to conrm the presence of the abscess, ascertain its location, assess
the feasibility of drainage, and determine the imaging modality that needs to be used for guidance. For ultrasound-guided
procedures, a screening USG must be performed to conrm
that the uid collection is accessible with USG guidance.
Prior to drainage of uid collections that are proven or suspected to be infected, empiric antibiotics are recommended
to reduce the risk of septicemia during puncture and catheter
manipulation. As intraabdominal abscesses are usually polymicrobial, antibiotics that cover gram-negative as well as
anaerobic bacteria are indicated. The recommended antibiotics include meropenem, piperacillin-tazobactam, and metronidazole with ciprooxacin, ceftazidime, or
ampicillin-sulbactam. For empyema, piperacillin- tazobactam
or amoxicillin-clavulanic acid which is effective against
gram-positive organisms is recommended [4].
Prior to the procedure, the patient should be explained
about the procedure and the risks associated with it. Written
informed consent should be obtained from all patients prior
to the procedure.
34.7 Basic Steps forAbscess Drainage
The basic steps for catheter drainage or needle aspiration of
abscesses are as follows:
• Patient assessment—Recent imaging studies of the patient
have to be reviewed prior to performing the procedure. A
screening of USG or CT is done to conrm the feasibility
of drainage and determine the path of needle entry. In
cases of uid collections that are located within solid
organs such as the liver or spleen, the catheter or the nee-
dle should be inserted through the normal parenchyma to
reduce the risk of rupture and bleeding. In patients with a
high risk of bleeding, the hemodynamic status of the
patient and coagulation prole should be assessed.
• Patient positioning—The patient is positioned in such a
way that the drainage catheter can be inserted into the
dependent portion of the abscess. The chosen patient
position should be comfortable enough so that the patient
lies still for the entire duration of the procedure. While
choosing the skin entry site for the catheter, it needs to be
ensured that the catheter wouldn’t cause much discomfort
to the patient while lying down.
• Cleaning and draping—The overlying skin is cleaned
using povidone-iodine and alcohol-based solution.
Draping is then done in such a way that only the cleaned
area is exposed.
• Anesthesia—Most drainage procedures are performed
under local anesthesia or conscious sedation. General anesthesia may be necessary for young children and uncooperative patients. Under all aseptic precautions, a local anesthetic
agent is inltrated into the overlying skin, and subcutaneous
tissue, along the intended course of the catheter or needle
insertion. A local anesthetic agent needs to be injected all
the way up to the pleural, peritoneal, or solid organ surface,
as they are pain sensitive. 2% lignocaine is the most commonly used local anesthetic agent, and the maximum dose
that can be administered is 4mg/kg for plain lignocaine and
7mg/kg for lignocaine with adrenaline.
• Drainage by catheter insertion/needle aspiration.
– Needle aspiration: An 18G needle is most commonly
used for single-time aspiration of uid collections. If
the contents are thick, a wide bore 16G needle may be
needed. The hypodermic needle is sufcient for
abscesses that are supercially located. Aspiration of
uid collections in joints or bursae should be done
using ne needles, 20G or thinner, to avoid injury to
overlying tendons and ligaments. Lumbar puncture
needles or Chiba needles are used for draining collections that are deeply placed.
– Catheter drainage: Pigtail catheters can be inserted by
two different techniques:
i. Trocar technique: In this technique, the catheter is
sheathed over a metallic cannula and puncture needle and inserted directly into the uid collection
after making a deep incision using a no.11 surgical
blade. The puncture needle is then removed and the
syringe is connected to the hub of the metallic cannula. The position of the catheter tip within the collection is conrmed by the aspiration of uid using
the syringe. The metallic cannula is then removed
and the pigtail catheter is advanced into the collection. The catheter is xed to the skin using adhesive
tapes or non-absorbable sutures.
ii. Seldinger technique: It involves initial puncture
using a puncture needle that consists of an inner needle and an outer cannula. Following the puncture, the
inner needle is taken out and the position is conrmed by the aspiration of uid through the outer
metallic cannula. A guidewire is then passed through
the metallic cannula. Keeping the guidewire in position, the metallic cannula is removed and the tract is
then dilated by inserting serial dilators over the
guidewire. Once the tract is sufciently dilated, the
catheter is inserted into the collection over the wire.
Following catheter insertion, it is connected to a drainage bag. If a catheter is inserted into the pleural cavity,
the drainage bag should contain an underwater seal to
prevent the development of pneumothorax.

430
V. P. Pulappadi and S. H. Chandrashekhara
34.8 Post-Procedure Care
Immediately after the procedure, the vitals of the patient
should be monitored for at least an hour to rule out any internal bleeding. The catheter should be ushed daily using normal saline to prevent clogging of the catheter due to debris.
The output from the catheter should be monitored daily.
Once the catheter drains <10ml per day for several days and
the patient shows clinical improvement, a repeat USG or CT
must be done to look for any residual uid collection. If no
residual collection is present, the catheter can be removed.
34.9 Complications
The common complications that occur during abscess drainage are [1] as follows:
• Bacteremia and septic shock: These may occur while
draining uid collections with bacterial colonization.
Transgression of bacteria into the bloodstream occurs as a
result of microtrauma to the walls of the collection during
manipulation of catheters or wires.
• Secondary infection of sterile uid collections: This can
happen due to inoculation of skin ora into the uid collection or into the bloodstream during the insertion of the
needle or the catheter.
• Hemorrhage: This usually occurs as a result of injury to
blood vessels that lie along the tract of catheter drainage.
Although it is usually self-limiting, life-threatening hemorrhage can occur if an artery is injured and bleeding
occurs into the pleural or peritoneal cavity. If hemodynamic instability develops after the procedure, USG needs
to be done to look for hemoperitoneum or hemothorax. If
the free uid is demonstrated on USG, CT angiography is
indicated to rule out active extravasation or pseudoaneurysm. If present, arterial injury can be treated by transarterial embolization.
• Bowel perforation: This can occur during drainage of
deep-seated uid collections. Care should be taken to
avoid the bowel while puncturing the collection. If small
bowel transgression is unavoidable, single-time aspiration of the collection can be performed using a ne needle. Large bowel should not be traversed during aspiration
of a sterile uid collection as it invariably results in the
seeding of colonic bacterial ora into the collection.
• Pneumothorax: This can occur during drainage of pleural
uid or as a result of pleural transgression during drainage of subdiaphragmatic or hepatic abscesses.
As per the SIR quality improvement guidelines, the sug-
gested threshold for major adverse events during percutaneous drainage procedures is 15% [1].
34.10 Specic Organ Considerations
34.10.1 Postoperative Fluid Collection
Routine imaging is not necessary during the postoperative
period as a uid collection is a common occurrence and
requires no treatment unless it is symptomatic. A postoperative uid collection could be an abscess, seroma, biloma,
hematoma, lymphocele, or urinoma. Postoperative uid collection is suspected when the patient complains of localized
abdominal pain, fever, or vomiting with leukocytosis and elevated C-reactive protein. USG is the screening imaging modality used in such suspected cases, while a CT scan is required
to rule out deep collections. Free uid and small uid collections are common ndings in the operative bed and do not
require drainage unless there is a suspicion of infection. Fluid
collections can arise as a result of anastomotic leaks following
resection anastomosis involving the gastrointestinal tract.
These are diagnosed on CT performed with oral contrast and
frequently require surgical repair. Biloma can occur following
biliary leaks after surgeries involving the liver and require
drainage if they are large and symptomatic [5].
34.10.2 Ascites
Ascites can occur due to various clinical conditions. In cases
where the cause of ascites is not evident, a diagnostic tap is
performed and the uid is examined for albumin levels, cell
counts, gram stain, and culture. USG guidance is necessary
when only a small amount of uid is present. Therapeutic drainage of ascitic uid is done when the patient develops respiratory
distress or severe abdominal distension. USG guidance is not
necessary in such cases unless septations are present in the ascites. Large volume paracentesis is also required in cases where
percutaneous hepatobiliary or other solid abdominal organ
interventions are planned to prevent the occurrence of intraperitoneal bleed. Long-term catheter drainage is most commonly
done in cases of malignancy and acute pancreatitis.
34.10.3 Liver Abscess
Hepatic abscesses most commonly occur as a result of the
seeding of microbes from the large intestine via the portal
venous system. It is also seen in patients with biliary obstruction, biliary-enteric anastomosis, or incompetent sphincter of
Oddi. Liver abscess drainage can be performed under USG
guidance in all cases except when it is obscured by air within
the lesion. Hepatic abscesses can either be pyogenic or be
amoebic. Pyogenic abscesses can be multiple and are common in alcoholics and the elderly. Amoebic abscesses are

34 Image-Guided Drainage Procedures
431
usually single and are associated with a lower incidence of
fever and jaundice. Pyogenic abscesses that are <3cm in size
can be managed by antibiotics along with single-time aspiration. Larger pyogenic abscesses require percutaneous catheter drainage. The features of amoebic abscesses that are
associated with a high risk of rupture are size >5cm, wall
thickness <1cm, or location within the left lobe (due to proximity to cardiac pulsations). The presence of these high-risk
features warrants percutaneous drainage in amoebic
abscesses apart from an increase in size on serial USG and a
lack of response to medical management.
Hydatid cyst is another infectious focal lesion that occurs
in the liver. PAIR (Puncture, Aspiration, Injection,
Reaspiration) is a percutaneous drainage technique used for
the treatment of hydatid cysts. It involves puncture and
aspiration of cyst uid, followed by injection of scolicidal
agent—95% ethanol solution or hypertonic saline (one-third
of the amount of aspirated uid) and reaspiration after ve
minutes. It is indicated in patients with (i) anechoic lesion
≥5 cm in diameter (CE1); (ii) cysts with daughter cysts
(CE2), and/or with the detachment of membranes (CE3);
(iii) multiple cysts if accessible to puncture, and (iv) infected
cysts. The other indications are cysts in pregnant women,
children >3years old, or in patients who refuse surgery or in
whom surgery is contraindicated, failure of chemotherapy,
and relapse after surgery. Contraindications for PAIR
include: (i) uncooperative patients and inaccessible or risky
location of the cyst in the liver; (ii) cyst in the spine, brain,
and/or heart; (iii) inactive or calcied lesion; (iv) cysts communicating with the biliary tree; (v) cysts opening into the
abdominal cavity, bronchi, and urinary tract [6].
34.10.4 Peripancreatic Fluid Collection
Acute pancreatitis and peripancreatic uid collections are
classied according to the revised Atlanta classication as
shown in Fig.34.2.
The indications for drainage of collections include the
presence of infection, mass effect on adjacent organs, persistent symptoms, and large collections >5cm in size that persist for more than 6weeks [7]. The mass effect may be in the
form of gastric outlet obstruction, biliary obstruction, ureteric obstruction, and portal hypertension. As far as possible,
the retroperitoneal route is preferred for the drainage of peripancreatic collections, as the same tract can be used for
endoscopic or minimally invasive necrosectomy (Fig.34.3).
Other approaches that can be used are transperitoneal
through the anterior abdominal wall and transhepatic and
transgastric routes. CT guidance is required when a retroperitoneal approach is used, while large collections reaching
up to the anterior abdominal wall can be targeted under USG
guidance if the patient is not hemodynamically stable enough
to be shifted for CT-guided drainage. The transverse colon
should be avoided while draining the collection via the anterior route due to the risk of the transgression of colonic bacteria into the collection. While infected collections need to
be drained immediately, sterile uid collections can be
drained after 3–4weeks once they liquefy. 10–12F pigtail
catheters can be used for the initial drainage. They can be
sequentially upgraded to 20–24F if adequate drainage is not
obtained with smaller bore catheters. Malecot catheter has
wider holes that help in better drainage of thick necrotic
debris.
Fig. 34.2 Revised Atlanta
classication for acute
pancreatitis
Acute Pancreatitis
Acute interstitial oedematous pancreatitis-
Inflammation in and around pancreas with no
pancreatic or peripancreatic necrosis
Acute peripancreatic fluid collection-
homogenous ill defined fluid collection
within 4 weeks of onset
Pseudocyst- homogenous fluid
collection with well defined walls, seen
after 4 weeks of onset
Acute necrotising pancreatitis- associated
with pancreatic and/or peripancreatic
necrosis
Acute necrotic collection- heterogenous
ill defined fluid collection within 4
weeks of onset
Walled off necrosis- heterogenous fluid
collection with thick well defined walls,
seen after 4 weeks of onset

432
ab c
Fig. 34.3 Pancreatic collection drainage. The pancreatic collections can be drained by placing the catheter anteriorly through transperitoneal route
(a), and posteriorly (b) and laterally through retroperitoneal route (c)
V. P. Pulappadi and S. H. Chandrashekhara
34.10.5 Splenic Abscess
Splenectomy had been the standard of care for splenic
abscesses before the advent of percutaneous drainage. USGguided drainage has the advantage of preserving the splenic
parenchyma, thereby avoiding the infectious complications
associated with splenectomy. Small abscesses can be treated
with antibiotics alone, while abscesses larger than 3 cm
require percutaneous drainage. The presence of multiple
abscesses that are refractory to medical management may
warrant splenectomy [8]. As splenic parenchyma is highly
vascular, single-time aspiration using a ne needle should be
considered as the rst line of therapy over large-bore pigtail
drainage.
34.10.6 Appendicitis
Fluid collection in the right iliac fossa can develop following
appendicitis and contain appendiceal perforation.
Percutaneous drainage along with antibiotics and bowel rest
constitutes the rst line of treatment for appendiceal uid
collections. The majority of the patients recover with nonoperative management, with a reduced complication rate as
compared to surgery [8].
for small abscesses that do not resolve with medical management. Large renal and perirenal abscesses require percutaneous catheter drainage.
34.10.9 Pelvic Abscess
Pelvis abscesses are usually tubo-ovarian in origin. They can
occur as a result of pelvic inammatory disease or after pelvic surgeries. These abscesses can be drained via transabdominal, transvaginal, transrectal, transperineal, or
transgluteal routes. For non-infected uid collections, the
sterile path through the transabdominal or transgluteal route
is preferred for drainage, while smaller infected uid
collections can be drained through transvaginal or transrectal
routes. Transabdominal drainage through the anterior
abdominal wall can be performed under ultrasound guidance
if they are large enough to be seen with transabdominal
USG.Transgluteal drainage requires CT guidance and is performed through the greater sciatic foramen, as medially and
inferiorly as possible to avoid injury to the sciatic nerve and
gluteal arteries [8].
34.10.10 Prostatic Abscess
34.10.7 Inammatory Bowel Disease
Abscesses associated with Crohn’s disease require treatment
with antibiotics, high-dose steroids, bowel rest, and percutaneous drainage. If percutaneous drainage fails, surgical
drainage and bowel resection will be necessary [8].
34.10.8 Renal Abscess
Renal abscesses are usually small and most often respond to
antibiotics alone. Single-time aspiration can be performed
Transurethral drainage is the rst-line treatment for prostatic
abscesses. However, transrectal ultrasound-guided drainage
is being increasingly used for draining these abscesses [8].
Most prostatic abscesses are small and usually respond to
single-time uid aspiration.
34.10.11 Pleural Eusion andEmpyema
Aspiration of pleural effusion can be performed to establish
the cause of effusion or as a therapeutic measure for relieving
respiratory distress. Diagnostic aspiration can be performed
using a ne gauge hypodermic or lumbar puncture needle.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
